Gastrointestinal cancer
Conditions
Interventions
Alfentanil group:Intravenous slow injection of alfentanil 10 ug/kg followed by intravenous injection of propofol 1.5 mg/kg
Sufentanil group:Intravenous injection of sufentanil 0.1 ug/kg, followed by intravenous injection of propofol 1.5 mg/kg after 2 min
Sponsors
Hebei Province Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Patients to undergo endoscopic ultrasonography; 2. Age is 18~65 years old, and gender is not limited; 3. Body mass index (BMI) of 18 to 30 kg/m^2; 4. American Association of Anesthesiologists (ASA) grade I~II.
Exclusion criteria
Exclusion criteria: 1. Patients who refuse to participate in the trial; 2. Those with a history of severe cardiac, cerebral, pulmonary, hepatic, or renal diseases; LVEF 1.5 times the upper limit of normal or GFR 180 mmHg and/or diastolic blood pressure > 110 mmHg, or hypotensive patients with blood pressure 100 beats/min; 5. Patients with anemia; 6. Those suspected of abusing narcotic analgesics or sedatives; 7. Those predicted to have or with a history of difficult airway; 8. Those known to be allergic to the drugs to be used; 9. Pregnant or breastfeeding women; 10. Those who are uncooperative or unable to communicate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of body movements; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total propofol dosage;Modified Aldrete Score;Oxygen saturation in PACU;Time to discharge; | — |
Countries
China
Contacts
Public ContactZhang Limin
Hebei Province Cangzhou Hospital of Integrated Traditional Chinese and Western Medicine
Outcome results
None listed